Writer Michelle Chen in her report on The Nation claims Congress’ health-care reform efforts “will actually make America sicker.”
“Perhaps the most paradoxical twist to Trump’s drug-price reform is that it purports to protect American consumers by exposing consumers in poorer countries to multinational pricing schemes,” Chen writes. “But health advocates say the reforms would only further rig the system in favor of Big Pharma, would do nothing for American patients at best, and at worst would harm even needier populations abroad.”
According to Chen, the order would lead to “regulatory relief for drug markets and health plans,” something she says is directly in line with pharma lobbyists’ demands. Chen added the order would hamper regulations which facilitate drug negotiations, too.
“The deepest harm may be felt outside American markets,” Chen writes. “One reported proposal, according to Kaiser Health News, would ease rules on extending patents for drugs exports, to ‘provide for protection and enforcement of intellectual property rights,’ supposedly to ensure ‘that American consumers do not unfairly subsidize research and development for people throughout the globe.'”